vs

Side-by-side financial comparison of Arena Group Holdings, Inc. (AREN) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $28.2M, roughly 1.3× Arena Group Holdings, Inc.). On growth, Arena Group Holdings, Inc. posted the faster year-over-year revenue change (-22.0% vs -57.1%). Over the past eight quarters, Arena Group Holdings, Inc.'s revenue compounded faster (-1.2% CAGR vs -46.5%).

Arena Racing Company, also called ARC Racing and Leisure Group is a UK private company, created in 2012 by the merger of Arena Leisure and Northern Racing. It owns and operates 16 racecourses in Great Britain, accounting for 39% of British racing fixtures. It also operates hotels at Wolverhampton Racecourse, Lingfield Park Racecourse and Doncaster Racecourse and golf courses at Lingfield, Southwell and Newcastle.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

AREN vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.3× larger
ORGO
$37.2M
$28.2M
AREN
Growing faster (revenue YoY)
AREN
AREN
+35.0% gap
AREN
-22.0%
-57.1%
ORGO
Faster 2-yr revenue CAGR
AREN
AREN
Annualised
AREN
-1.2%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AREN
AREN
ORGO
ORGO
Revenue
$28.2M
$37.2M
Net Profit
$5.3M
Gross Margin
43.6%
30.8%
Operating Margin
26.6%
-185.1%
Net Margin
18.9%
Revenue YoY
-22.0%
-57.1%
Net Profit YoY
-22.5%
EPS (diluted)
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AREN
AREN
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$28.2M
$225.6M
Q3 25
$29.8M
$150.9M
Q2 25
$45.0M
$101.0M
Q1 25
$31.8M
$86.7M
Q4 24
$36.2M
$126.7M
Q3 24
$33.6M
$115.2M
Q2 24
$27.2M
$130.2M
Net Profit
AREN
AREN
ORGO
ORGO
Q1 26
Q4 25
$5.3M
$43.7M
Q3 25
$6.9M
$21.6M
Q2 25
$108.6M
$-9.4M
Q1 25
$4.0M
$-18.8M
Q4 24
$6.9M
$7.7M
Q3 24
$4.0M
$12.3M
Q2 24
$-8.2M
$-17.0M
Gross Margin
AREN
AREN
ORGO
ORGO
Q1 26
30.8%
Q4 25
43.6%
Q3 25
50.2%
Q2 25
56.5%
Q1 25
49.3%
72.6%
Q4 24
52.6%
75.5%
Q3 24
50.6%
76.7%
Q2 24
39.4%
77.6%
Operating Margin
AREN
AREN
ORGO
ORGO
Q1 26
-185.1%
Q4 25
26.6%
28.1%
Q3 25
31.9%
13.7%
Q2 25
36.5%
-12.5%
Q1 25
23.1%
-30.9%
Q4 24
28.6%
8.1%
Q3 24
24.0%
5.4%
Q2 24
-9.5%
-10.7%
Net Margin
AREN
AREN
ORGO
ORGO
Q1 26
Q4 25
18.9%
19.4%
Q3 25
23.1%
14.3%
Q2 25
241.4%
-9.3%
Q1 25
12.6%
-21.7%
Q4 24
19.0%
6.1%
Q3 24
11.8%
10.7%
Q2 24
-30.1%
-13.1%
EPS (diluted)
AREN
AREN
ORGO
ORGO
Q1 26
Q4 25
$0.12
$0.31
Q3 25
$0.14
$0.11
Q2 25
$2.28
$-0.10
Q1 25
$0.08
$-0.17
Q4 24
$1.23
$0.05
Q3 24
$0.11
$0.09
Q2 24
$-0.28
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AREN
AREN
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$10.3M
$91.4M
Total DebtLower is stronger
$97.6M
Stockholders' EquityBook value
$-4.8M
Total Assets
$112.6M
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AREN
AREN
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$10.3M
$93.7M
Q3 25
$12.5M
$63.7M
Q2 25
$6.8M
$73.1M
Q1 25
$2.9M
$110.0M
Q4 24
$4.4M
$135.6M
Q3 24
$5.8M
$94.3M
Q2 24
$6.1M
$89.9M
Total Debt
AREN
AREN
ORGO
ORGO
Q1 26
Q4 25
$97.6M
Q3 25
$110.5M
Q2 25
$110.5M
Q1 25
$110.5M
Q4 24
$110.4M
Q3 24
$102.4M
$62.3M
Q2 24
$102.4M
$63.8M
Stockholders' Equity
AREN
AREN
ORGO
ORGO
Q1 26
Q4 25
$-4.8M
$300.1M
Q3 25
$-10.4M
$255.1M
Q2 25
$-17.3M
$233.2M
Q1 25
$-126.1M
$242.9M
Q4 24
$-130.3M
$262.9M
Q3 24
$-137.5M
$278.5M
Q2 24
$-157.2M
$263.5M
Total Assets
AREN
AREN
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$112.6M
$598.7M
Q3 25
$121.4M
$509.8M
Q2 25
$127.8M
$461.1M
Q1 25
$114.6M
$467.4M
Q4 24
$116.4M
$497.9M
Q3 24
$114.2M
$446.3M
Q2 24
$113.4M
$443.2M
Debt / Equity
AREN
AREN
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AREN
AREN
ORGO
ORGO
Operating Cash FlowLast quarter
$13.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.46×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AREN
AREN
ORGO
ORGO
Q1 26
Q4 25
$13.1M
$39.4M
Q3 25
$12.2M
$3.1M
Q2 25
$10.3M
$-32.9M
Q1 25
$3.7M
$-19.9M
Q4 24
$-8.6M
$10.9M
Q3 24
$-2.3M
$8.7M
Q2 24
$-3.2M
$4.7M
Free Cash Flow
AREN
AREN
ORGO
ORGO
Q1 26
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$-2.4M
$6.1M
Q2 24
$2.9M
FCF Margin
AREN
AREN
ORGO
ORGO
Q1 26
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
-7.1%
5.3%
Q2 24
2.2%
Capex Intensity
AREN
AREN
ORGO
ORGO
Q1 26
Q4 25
2.1%
Q3 25
0.0%
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
0.1%
2.2%
Q2 24
1.4%
Cash Conversion
AREN
AREN
ORGO
ORGO
Q1 26
Q4 25
2.46×
0.90×
Q3 25
1.77×
0.14×
Q2 25
0.09×
Q1 25
0.91×
Q4 24
-1.25×
1.43×
Q3 24
-0.59×
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons